A prospective study of swallowing and voice outcomes after treatment for small-cell lung cancer

Lung cancer remains the most common cancer in the world, with high incidence and mortality rates. Patients with lung cancer are at risk of swallowing problems (dysphagia) and voice problems (dysphonia) due to the cancer itself or its subsequent treatment. Dysphagia in particular can be devastating, and if severe may cause fatal complications. This study will investigate swallowing and voice problems prior to and again after treatment in patients with small-cell lung cancer, to gain a detailed insight into the extent and nature of this problem so that patients can be more appropriately managed and significant treatment complications avoided.


Peter MacCallum Cancer Centre


Victorian Cancer Agency

Principal Investigator/s

Dr Jacqui Frowen, Clinical Lead of Speech Pathology


Dr Jacqui Frowen

Principle Investigator

Email: [email protected]